Laurion Capital Management »

Tscan Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9M 363k 7.94
2023-12-31 $352k 60k 5.83

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Broadcom Call Option (AVGO)
Ishares Tr Msci Eafe Etf (EFA)
Tesla Motors Call Option (TSLA)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Home Depot (HD)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)

View all positions for Laurion Capital Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
Adage Capital Partners GP
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
BlackRock
Deer Management
Alphabet
Simplify Asset Management
Geode Capital Management
Millennium Management
Laurion Capital Management
Susquehanna International

View all funds holding Tscan Therapeutics